← Back to Patent Explorer
US4738932A Expired / Lapsed US ⏱️ 0.0 years remaining

Reaginic test for syphilis

Assignee: Heron Therapeutics LLC
•
Filing: 1985-12-03
•
Granted: 1988-04-19
•
Expires: 2005-12-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A reaginic agglutination test for syphilis-associated antibodies is disclosed. The test uses an antigen reagent that comprises a buffered aqueous suspension of cardiolipin antigen ionically coupled to latex particles via a polypeptide bridge. Positive sera react with the antigen reagent and yield an agglutination pattern characterized by medium to large aggregates. Negative sera yield no agglutinated particles.

Inventors

  • 👤 Kenichi K. Yabusaki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 18:19
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/569; G01N33/571; G01N33/54313; G01N33/54353; G01N33/54393; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S436/00; Y10S436/807; Y10S436/808; Y10S436/811

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 29 words
An antigen reagent for use in a reaginic test for syphilis comprising an aqueous suspension of cardiolipin antigen ionically coupled to latex particles via a positively charged polypeptide bridge.
Claim 2
Dependent Claim 29 words
An antigen reagent for use in a reaginic test for syphilis comprising an aqueous suspension of cardiolipin antigen ionically coupled to latex particles via a positively charged polypeptide bridge.
Claim 3
Dependent Claim 21 words
The reagent of claim 1 wherein the latex particles are neutral or modified to have negatively charged or reactive surface moieties.
Claim 4
Dependent Claim 21 words
The reagent of claim 1 wherein the particle size of the latex is in the range of 0.1 to 7 microns.
Claim 5
Dependent Claim 21 words
The reagent of claim 1 wherein the particle size of the latex is in the range of 0.4 to 0.8 microns.
Claim 6
Dependent Claim 13 words
The reagent of claim 1 wherein the polypeptide is a polycationic polyamino acid.
Claim 7
Dependent Claim 10 words
The reagent of claim 1 wherein the polypeptide is polylysine.
Claim 8
Dependent Claim 21 words
The reagent of claim 1 wherein the cardiolipin antigen is an ethanol solution of 0.03% cardiolipin, 0.9% cholesterol and 0.21% lecithin.
Claim 9
Dependent Claim 19 words
The reagent of claim 1 wherein the aqueous suspension is buffered to a pH in the range of 5-10.
Claim 10
Dependent Claim 18 words
The reagent of claim 1 wherein the aqueous suspension is buffered at a pH of 6.0 to 7.0.
Claim 11
Dependent Claim 87 words
The reagent of claim 1 wherein the particle size of the latex is in the range of 0.4 to 0.8 microns, the latex is a carboxylated latex, the polypeptide bridge is a methylated serum albumin or polylysine bridge, the cardiolipin antigen is an ethanol solution of 0.03% cardiolipin, 0.9% cholesterol and 0.21% lecithin, the suspension is buffered to a pH of 6.0 to 6.5, and the concentration of cardiolipin antigen ionically coupled to latex particles via a polypeptide bridge in the suspension is 0.3 to 0.9 mg/ml.
Claim 12
Dependent Claim 56 words
A reaginic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 1 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 13
Dependent Claim 56 words
A reaginic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 5 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 14
Dependent Claim 56 words
A serologic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 6 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 15
Dependent Claim 56 words
A serologic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 7 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 16
Dependent Claim 56 words
A serologic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 8 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 17
Dependent Claim 56 words
A serologic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 10 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 18
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 1; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 19
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 5; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 20
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 6; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 21
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 7; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 22
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 8; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 23
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 10; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.
Claim 24
Dependent Claim 12 words
The reagent of claim 1 wherein the polypeptide is methylated serum albumin.
Claim 25
Dependent Claim 56 words
A reaginic test for syphilis-associated antibodies comprising: (a) incubating a sample suspected of containing said antibodies with the antigen reagent of claim 23 under conditions that permit binding between said antibodies and antigen in said antigen reagent; and (b) determining whether the antigen reagent has agglutinated, agglutination indicating the presence of said antibodies in said sample.
Claim 26
Dependent Claim 70 words
A kit for conducting a serologic test for syphilis-associated antibodies comprising, in packaged combination: (a) a first container containing the antigen reagent of claim 23; (b) a second container containing a negative control sample of serum, plasma, or cerebrospinal fluid that does not react with the antigen reagent; and (c) a third container containing a positive control sample of serum, plasma, or cerebrospinal fluid that reacts with the antigen reagent.

References Cited (Backward Citations)

US4264766A Cited
US3564089A Cited
US3720760A Cited
US3720760B1 Cited
US4272510A Cited
US4226847A Cited
US4181636A Cited
US4218335A Cited
US4572901A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-04-19 1991-10-19 1992-04-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-04-19 1995-10-19 1996-04-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-04-19 1999-10-19 2000-04-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag